49F-22973-51753
1 vaccination
2 coded responses
2 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 231 / VA
- Registered
- 2022-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-02-10
Dose 1 — Pfizer-BioNTech
-
2022-02-20
Registered in v-safe
-
2022-02-20
Survey response — day 7, dose 1MedDRA: Abortion spontaneous, Alopecia — Feeling: Fair · Site: Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Hair loss, also just suffered a miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-10
Survey response — day 28, dose 1MedDRA: Alopecia, Rash, Sensitive skin — Feeling: FairFree text: Hair loss sensitive skin rashesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-10 | Pfizer-BioNTech | No |
Free text
Release 11 — day 7, dose 1
Systemic reaction (other): Hair loss, also just suffered a miscarriage
Release 11 — day 28, dose 1
Symptoms: Hair loss sensitive skin rashes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Sensitive skin | · | · | ✓ |
| SRO | Abortion spontaneous | · | · | ✓ |
| SRO | Alopecia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release